Kenneth Erland Johnson
CIK 1743774 · View on SEC EDGAR ↗
First SEC filing: Oct. 5, 2021 · Latest: Oct. 5, 2021
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 5, 2021 | XERS | A | 21,401 | — | — | 21,401 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 5, 2021 | XERS | A | 32,500 | — | — | 32,500 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 5, 2021 | XERS | A | 100,000 | — | — | 100,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 5, 2021 | XERS | A | 39,633 | — | — | 39,633 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 5, 2021 | XERS | A | 5,280 | — | — | 5,280 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 5, 2021 | XERS | A | 33,686 | — | — | 33,686 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 5, 2021 | XERS | A | 78,333 | — | — | 89,583 Direct | +696.29% | Acquired | (price as of 2026-08-21) |
| Oct. 5, 2021 | XERS | A | 11,250 | — | — | 11,250 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 5, 2021 | XERS | Stock Option (Right to Buy) | Common Stock (21,401) | $19.00 | Oct. 4, 2028 | 21,401 | Acquired |
| Oct. 5, 2021 | XERS | Stock Option (Right to Buy) | Common Stock (32,500) | $13.88 | Jan. 31, 2029 | 32,500 | Acquired |
| Oct. 5, 2021 | XERS | Stock Option (Right to Buy) | Common Stock (100,000) | $3.94 | Aug. 14, 2030 | 100,000 | Acquired |
| Oct. 5, 2021 | XERS | Stock Option (Right to Buy) | Common Stock (39,633) | $5.93 | Jan. 31, 2028 | 39,633 | Acquired |
| Oct. 5, 2021 | XERS | Stock Option (Right to Buy) | Common Stock (5,280) | $1.55 | June 12, 2027 | 5,280 | Acquired |
| Oct. 5, 2021 | XERS | Stock Option (Right to Buy) | Common Stock (33,686) | $1.55 | Feb. 4, 2027 | 33,686 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $414,102 | — | $430,500 | — | $182,205 | — | $31,622 | $1,058,429 |
| 2023 | $398,174 | — | $124,000 | — | $191,738 | — | $7,055 | $720,967 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.